McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q1 2026 holdings
- Shares (Q1 2026)
- 52
- Value
- $27.2K
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 52 | $27.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 52 | $30.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 52 | $23.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 52 | $15.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 52 | $17.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 52 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 52 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 52 | $14.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 52 | $13.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 52 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 52 | $7.59K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 52 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 52 | $12.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 52 | $15.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 52 | $3.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 52 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 52 | $5.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 52 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 52 | $4.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 52 | $5.00K | <0.1% | +52 | New | Holders |